It is currently Sat Aug 29, 2015 6:47 pm

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

Stem Cells

I post it in Drug pipeline by error and also here because I think it gives good vibrations

Take a look at this interesting trial.

"Stem Cell Therapy In Multiple Sclerosis - Now It Is Time To Really Start" ... N=50664116

Read more : Stem Cells | Views : 858 | Replies : 0 | Forum : General Discussion

Stem Cells

Take a look at this interesting trial.

"Stem Cell Therapy In Multiple Sclerosis - Now It Is Time To Really Start" ... N=50664116

Read more : Stem Cells | Views : 1439 | Replies : 3 | Forum : Drug Pipeline

Stem Cell Therapy... Now?

Stem Cell Therapy In Multiple Sclerosis - Now It Is Time To Really Start
Main Category: Multiple Sclerosis News
Article Date: 24 Nov 2006 - 0:00am (PST)
Stem Cell Research

Clinical research with human stem cells to repair brain damage in MS patients should be intensified. Although not unanimously, this was the main conclusion of an international medical scientific conference on MS and stem cell therapy in Italy today, organised by the independent European Charcot ...
Read more : Stem Cell Therapy... Now? | Views : 2414 | Replies : 3 | Forum : Stem Cells

New trial of MBP8298 for RRMS

This just in...

BioMS Medical commences enrolment in a relapsing remitting multiple sclerosis trial

November 23 / CNW / - BioMS Medical today announced that the first patients have been enrolled in its placebo controlled multi-center Phase II clinical trial of MBP8298 for the treatment of relapsing remitting multiple sclerosis (RRMS).

"This is a major milestone in our strategy to advance our lead drug into a second indication," said Mr. Kevin Giese, President of BioMS ...
Read more : New trial of MBP8298 for RRMS | Views : 1281 | Replies : 3 | Forum : Drug Pipeline

human endogenous retrovirus

human endogenous retrovirus seems to be another virus to add to the list of suspects along with EBV and HHV6.

Gene-environment interactions in multiple sclerosis: Innate and adaptive immune responses to human endogenous retrovirus and herpesvirus antigens and the lectin complement activation pathway.

J Neuroimmunol. 2006 Nov 15;
Christensen T, Petersen T, Thiel S, Brudek T, Ellermann-Eriksen S, Moller-Larsen A.
Institute of Medical Microbiology and Immunology, Bartholin Building, University of Aarhus, DK-8000 Aarhus C, Denmark. ...
Read more : human endogenous retrovirus | Views : 1231 | Replies : 3 | Forum : General Discussion

Epigenetics radio program

I just heard a podcast of a CBC (Canadian Broadcasting Corp for the non-Canadians out there) radio program on epigenetics. It isn't about MS specifically, but if you are at all curious about epigenetics, it's an enjoyable, accessible introduction. From the attached link, it's the November 22 selection.
Read more : Epigenetics radio program | Views : 1139 | Replies : 2 | Forum : General Discussion

Dr Freedman Interview on ECTRIMS

From Medscape Neurology & Neurosurgery

Expert Interview
New Perspectives in Multiple Sclerosis: An Expert Interview With Mark S. Freedman, HBSc, MSc, MD
Posted 11/01/2006

The 22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) was held from September 27 to 30, 2006 in Madrid, Spain. During this meeting, new information about the diagnosis and management of multiple sclerosis (MS) was presented. Marni Kelman, MSc, Medscape Neurology & Neurosurgery Editorial Director, ...
Read more : Dr Freedman Interview on ECTRIMS | Views : 1751 | Replies : 6 | Forum : General Discussion

Calpain Inhibitor

Read more : Calpain Inhibitor | Views : 1533 | Replies : 7 | Forum : General Discussion

A little info about daclizumab trial

From a longer news item today, there was one paragraph about the phase 2 daclizumab MS trial.

PDL says Roche ends organ transplant drug venture

McDade said PDL continues to support the ongoing studies of daclizumab in relapsing/remitting multiple sclerosis, and anticipates results from a Phase 2 testing the drug in combination with beta-interferon during 2007. ... &type=qcna
Read more : A little info about daclizumab trial | Views : 1091 | Replies : 0 | Forum : Drug Pipeline


Read more : Asthma | Views : 3398 | Replies : 28 | Forum : General Discussion


Login  •  Register


Total posts 227072 • Total topics 23943 • Total members 15241

Contact us | Terms of Service